🇺🇸 FDA
Patent

US 10363237

Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

granted A61KA61K31/165A61K31/195

Quick answer

US patent 10363237 (Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase) held by The Regents of the University of California expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/165, A61K31/195, A61K31/337, A61K31/365